APA (7th ed.) Citation

Şatırtav, G., Lövestam-Adrian, M. K., Chang, W., Charles, M., Chen, L., Cheung, C. M. G., . . . Wolf, S. (2026). Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval. Clinical Ophthalmology, 20, 1. https://doi.org/10.2147/OPTH.S587803

Chicago Style (17th ed.) Citation

Şatırtav, Günhal, et al. "Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval." Clinical Ophthalmology 20 (2026): 1. https://doi.org/10.2147/OPTH.S587803.

MLA (9th ed.) Citation

Şatırtav, Günhal, et al. "Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval." Clinical Ophthalmology, vol. 20, 2026, p. 1, https://doi.org/10.2147/OPTH.S587803.